Who is sponsoring NCT03090347?

NCT03090347 is sponsored by University of Oxford.

What drugs are being tested in NCT03090347?

Interventions in NCT03090347: Overconsumption of specific dietary nutrient.

What condition does NCT03090347 study?

NCT03090347 studies NAFLD, Nutrient; Excess.

Is NCT03090347 still recruiting?

NCT03090347 is currently status unknown. Last updated 7 June 2022.

Last reviewed 2022-06-07 · How we verify

NCT03090347

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Dietary Nutrients on Liver and Adipose Tissue Metabolism

Status unknown NA Last updated 7 June 2022

What this trial tests

NA trial testing Overconsumption of specific dietary nutrient in NAFLD in 100 participants. Status unknown.

Timeline

1 March 2017

Primary endpoint
31 March 2023

31 March 2023

Quick facts

Lead sponsor	University of Oxford
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	100
Start date	1 March 2017
Primary completion	31 March 2023
Estimated completion	31 March 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Overconsumption of specific dietary nutrient

Conditions studied

NAFLD — all drugs for NAFLD →
Nutrient; Excess — all drugs for Nutrient; Excess →

Sponsor

University of Oxford

Who can join

Adults 18 to 65, any sex, with NAFLD or Nutrient; Excess. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In health,adipose tissue stores fat from the diet. If the fat tissue stops storing dietary fat then this increases the chance of it being stored in the liver, which is related to increased risk of heart disease and type 2 diabetes. It has been suggested that having a diet high in sugars or certain fats, may cause the fat tissue and liver to change how they function; we would like to investigate this in detail.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The influence of nutritional state on the fatty acid composition of circulating lipid fractions: implications for their use as biomarkers of dietary fat intake.
Parry SA, Rosqvist F, Peters S, Young RK, et al · · 2021 · cited 4× · PMID 34471486 · DOI 10.48101/ujms.v126.7649
Using total plasma triacylglycerol to assess hepatic <i>de novo</i> lipogenesis as an alternative to VLDL triacylglycerol.
Hodson L, Parry SA, Cornfield T, Charlton C, et al · · 2020 · cited 4× · PMID 32208800 · DOI 10.1080/03009734.2020.1739789

Verify or expand the search:

Other recruiting trials for NAFLD

Currently open trials in the same condition.

NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
NCT06661655 — Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients · NA · recruiting
NCT07093346 — The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patient · NA · recruiting
NCT06879236 — Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease · recruiting
NCT06888310 — Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease · NA · recruiting

Other University of Oxford trials

Trials by the same sponsor.

NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03090347 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oxford
Last refreshed: 7 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03090347.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing